aPL antibodies have been identified as agents involved in the vascular pathway of NPSLE pathogenesis, leading to various adverse outcomes such as strokes, venous thromboembolism, cerebral venous sinus thrombosis, cognitive impairment, peripheral neuropathy, and chorea. The gene discussed is FASLG; the disease is stroke disorder.